CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.92 +0.02 (+2.22%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Change in Acquisitions & Divestments (2023 - 2025)

Updated

CytoMed Therapeutics (GDTC) reported Change in Acquisitions & Divestments of $212,552 for FY2025, down 88.4% from $1.83 million in FY2024.

Analysis

CytoMed Therapeutics (GDTC) Change in Acquisitions & Divestments (2023 - 2025) Analysis & Trends

  • According to Business Quant data, Change in Acquisitions & Divestments came in at $1.83 million in FY2024 and -$2.06 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CytoMed Therapeutics 10.88 Mn -200,496.58 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 273,320.00
Jun 30, 2024 -477,677.00
Jun 30, 2023 -5.44 Mn
API Access

CytoMed Therapeutics Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=GDTC&period=max&api_key=YOUR_API_KEY